<DOC>
	<DOCNO>NCT00274677</DOCNO>
	<brief_summary>This study 8-week evaluation investigational drug treat depression bipolar patient . Depressed patient give either investigational drug placebo receive psychiatric assessment depression weekly visit . Study drug study-related visit provide cost patient . The patient agree meet study research staff roughly 11 clinic visit .</brief_summary>
	<brief_title>Depression And Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Inclusion Patients must provide write informed consent . Diagnosis Bipolar II Disorder currently depress minimum last 8 week . Exclusion Patients must suicidal . Patients must history nonresponse antidepressant treatment . Patients must clinical history substance dependence past year abuse within 4 week prior study entry . Patients must epilepsy hypothyroidism .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Bipolar Disorder</keyword>
</DOC>